The Future of the ACA and Plans to Repeal: Dr Patricia Salber Interviews Dr Joe Antos

There are a lot of unknowns about how Republicans will move to repeal and replace the Affordable Care Act now that they will have a Republican in the White House. Joe Antos, PhD, resident scholar at the American Enterprise Institute, did his best to speculate how a repeal might play out and what will happen with Medicaid expansion under a Trump presidency.

Related Videos

Related Content

Advertisement

September 18th 2024

Inflation Reduction Act: A Battleground for Health Care Policy

Maggie L. Shaw

The Inflation Reduction Act was signed into law on August 16, 2022, and the debate over its Medicare-related benefits and impact on the prescription drug market has been raging ever since.

September 17th 2024

Frameworks for Advancing Health Equity: Youth Behavioral Health Strategy Program

Giuliana Grossi

Chris Barton, LCSW, of Horizon Blue Cross Blue Shield of New Jersey, explores how the Youth Behavioral Health Strategy program focuses on addressing the specific needs of youth with mental health and substance use issues through a comprehensive approach.

September 18th 2024

It’s Time to Address Our Nation’s Health Care Price Crisis

Guy D’Andrea, MBA Torie Nugent-Peterson

This commentary introduces Catalyst for Payment Reform’s and the Employers’ Forum of Indiana’s new campaign, Price Crisis, which will mobilize individuals, employers, and policy makers with evidence, guidance, and resources to take meaningful actions.

September 16th 2024

Healing Wounds Through Peer Support

Maggie L. Shaw

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this third episode, we speak with Kim MacDonald-Wilson, ScD, CPRP, and Tracy Carney, CPS, CPRP.

September 17th 2024

Review: Idiopathic Hypersomnia Carries Considerable Burden and Remains Poorly Defined

Kyle Munz

A systematic review on diagnostic challenges and burden related to idiopathic hypersomnia gave insights into the extensive difficulties associated with the condition.

September 17th 2024

Bridging Global Treatment Gaps in Relapsed Multiple Myeloma

Maggie L. Shaw

The principal goal of therapies for multiple myeloma, which remains incurable, is to extend progression-free survival, but challenges remain bringing chimeric antigen receptor T-cell therapy to the world, explains Leland Metheny, MD, lead investigator for the phase 1 BAFF CAR T clinical trial, University Hospitals Seidman Cancer Center.

Related Content

Advertisement

September 18th 2024

Inflation Reduction Act: A Battleground for Health Care Policy

Maggie L. Shaw

The Inflation Reduction Act was signed into law on August 16, 2022, and the debate over its Medicare-related benefits and impact on the prescription drug market has been raging ever since.

September 17th 2024

Frameworks for Advancing Health Equity: Youth Behavioral Health Strategy Program

Giuliana Grossi

Chris Barton, LCSW, of Horizon Blue Cross Blue Shield of New Jersey, explores how the Youth Behavioral Health Strategy program focuses on addressing the specific needs of youth with mental health and substance use issues through a comprehensive approach.

September 18th 2024

It’s Time to Address Our Nation’s Health Care Price Crisis

Guy D’Andrea, MBA Torie Nugent-Peterson

This commentary introduces Catalyst for Payment Reform’s and the Employers’ Forum of Indiana’s new campaign, Price Crisis, which will mobilize individuals, employers, and policy makers with evidence, guidance, and resources to take meaningful actions.

September 16th 2024

Healing Wounds Through Peer Support

Maggie L. Shaw

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this third episode, we speak with Kim MacDonald-Wilson, ScD, CPRP, and Tracy Carney, CPS, CPRP.

September 17th 2024

Review: Idiopathic Hypersomnia Carries Considerable Burden and Remains Poorly Defined

Kyle Munz

A systematic review on diagnostic challenges and burden related to idiopathic hypersomnia gave insights into the extensive difficulties associated with the condition.

September 17th 2024

Bridging Global Treatment Gaps in Relapsed Multiple Myeloma

Maggie L. Shaw

The principal goal of therapies for multiple myeloma, which remains incurable, is to extend progression-free survival, but challenges remain bringing chimeric antigen receptor T-cell therapy to the world, explains Leland Metheny, MD, lead investigator for the phase 1 BAFF CAR T clinical trial, University Hospitals Seidman Cancer Center.